Affibody
Phase 1The next generation radiopharmaceuticals Affibody is a biotechnology company developing next generation radiopharmaceuticals based on our proprietary Affibody® platform
Founded
1998
Focus
AntibodiesBiologics
About
The next generation radiopharmaceuticals Affibody is a biotechnology company developing next generation radiopharmaceuticals based on our proprietary Affibody® platform
Funding History
3Total raised: $210M
Series C$110MHealthCapJun 15, 2022
Series B$75MHealthCapJun 15, 2020
Series A$25MHealthCapJun 15, 2018
Company Info
TypePrivate
Founded1998
LocationSolna, Sweden
StagePhase 1
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Alligator Bioscience
Phase 1 · Lund
Amferia Kills Bacteria
Pre-clinical · Gothenburg
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile